Relationship of cardiometabolic parameters in non-smokers, current smokers, and quitters in diabetes: a systematic review and meta-analysis
- PMID: 27881170
- PMCID: PMC5121966
- DOI: 10.1186/s12933-016-0475-5
Relationship of cardiometabolic parameters in non-smokers, current smokers, and quitters in diabetes: a systematic review and meta-analysis
Abstract
Background: Smoking is associated with increased macrovascular and microvascular complications in people with diabetes. In addition to other concomitant vascular perturbations, it also seems to influence the cardiometabolic parameters, which may partly explain the accelerated rate of vascular complications in smokers with diabetes. While smoking cessation is advocated as a universal component of the management of diabetes, there is some anecdotal evidence that HbA1c could increase following smoking cessation. The aim of this review is to explore the relationship between smoking and its cessation on cardiometabolic parameters in diabetes.
Methods: Searches were conducted on Medline, EMBASE and CINAHL up to March 2016. After screening 6866 studies (Additional file 1), 14 observational studies with a total of 98,978 participants' with either type 1 or type 2 diabetes were selected for review. Narrative synthesis and meta-analyses were carried out to explore the relationship between smoking and its cessation.
Results: Meta-analysis showed that the pooled mean difference of HbA1c between non-smokers and smokers was -0.61% (95% CI -0.88 to -0.33, p < 0.0001). The difference in LDL cholesterol between non-smokers and smokers was -0.11 mmol/l (95% CI -0.21 to -0.01, p = 0.04). The difference in HDL cholesterol between non-smokers and smokers was 0.12 mmol/l (95% CI 0.08-0.15, p < 0.001). However, there was no statistically significant difference in blood pressure between the two groups. The difference in HbA1c between quitters and continued smokers was not statistically significant -0.10% (95% CI -0.42 to 0.21, p = 0.53). However, a narrative synthesis revealed that over a period of 10 years, the HbA1c was comparable between non-smokers and quitters.
Conclusion: Non-smokers have a statistically significant lower HbA1c and more favourable lipid profile compared to smokers. Smoking cessation does not lead to an increase in HbA1c in long-term and may reduce vascular complications in diabetes by its favourable impact on lipid profile.
Keywords: Diabetes; Glycosylated haemoglobin (HbA1c); Low density lipoprotein (LDL) and high density lipoprotein (HDL) cholesterol: blood pressure (systolic and diastolic—SBP and DBP); Smoking; Smoking cessation.
Figures
Similar articles
-
Type 1 diabetes in Cheshire: cardiometabolic risk factor trends (2004-2009).Prim Care Diabetes. 2012 Jul;6(2):123-6. doi: 10.1016/j.pcd.2011.10.007. Epub 2011 Dec 3. Prim Care Diabetes. 2012. PMID: 22137766
-
log(TG)/HDL-C is related to both residual cardiometabolic risk and β-cell function loss in type 2 diabetes males.Cardiovasc Diabetol. 2010 Dec 14;9:88. doi: 10.1186/1475-2840-9-88. Cardiovasc Diabetol. 2010. PMID: 21156040 Free PMC article.
-
Smoking and lipid-related indices in patients with diabetes mellitus.Diabet Med. 2014 Jul;31(7):868-78. doi: 10.1111/dme.12430. Epub 2014 Apr 4. Diabet Med. 2014. PMID: 24606550
-
Omega-3 polyunsaturated fatty acids favourably modulate cardiometabolic biomarkers in type 2 diabetes: a meta-analysis and meta-regression of randomized controlled trials.Cardiovasc Diabetol. 2018 Jul 7;17(1):98. doi: 10.1186/s12933-018-0740-x. Cardiovasc Diabetol. 2018. PMID: 29981570 Free PMC article. Review.
-
Web-Based Interventions _targeting Cardiovascular Risk Factors in Middle-Aged and Older People: A Systematic Review and Meta-Analysis.J Med Internet Res. 2016 Mar 11;18(3):e55. doi: 10.2196/jmir.5218. J Med Internet Res. 2016. PMID: 26968879 Free PMC article. Review.
Cited by
-
Smoking cessation and risk of metabolic syndrome: A meta-analysis.Medicine (Baltimore). 2024 May 31;103(22):e38328. doi: 10.1097/MD.0000000000038328. Medicine (Baltimore). 2024. PMID: 39259087 Free PMC article.
-
Exploring HbA1c variation between Australian diabetes centres: The impact of centre-level and patient-level factors.PLoS One. 2022 Feb 4;17(2):e0263511. doi: 10.1371/journal.pone.0263511. eCollection 2022. PLoS One. 2022. PMID: 35120182 Free PMC article.
-
Joint Effect of Maternal Tobacco Smoking and Pregestational Diabetes on Preterm Births and Congenital Anomalies: A Population-Based Study in Northern Italy.J Diabetes Res. 2018 Jun 28;2018:2782741. doi: 10.1155/2018/2782741. eCollection 2018. J Diabetes Res. 2018. PMID: 30050951 Free PMC article.
-
The relationship between smoking cigarettes and metabolic syndrome: A cross-sectional study with non-single residents of Seoul under 40 years old.PLoS One. 2021 Aug 19;16(8):e0256257. doi: 10.1371/journal.pone.0256257. eCollection 2021. PLoS One. 2021. PMID: 34411160 Free PMC article.
-
Association of smoking and cardiometabolic parameters with albuminuria in people with type 2 diabetes mellitus: a systematic review and meta-analysis.Acta Diabetol. 2019 Aug;56(8):839-850. doi: 10.1007/s00592-019-01293-x. Epub 2019 Feb 24. Acta Diabetol. 2019. PMID: 30799525 Free PMC article.
References
-
- Bornemisza P, Suciu I. Effect of cigarette smoking on the blood glucose level in normals and diabetics. Med Interne. 1980;18(4):353–356. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical